Cytek Biosciences, Inc. CTKB Market capitalization

Market capitalization at other companies

Becton, Dickinson and CompanyBDX

$41.7B-15.2%

Thermo Fisher ScientificTMO

$190.65B+24.9%

DanaherDHR

$134.82B-4.6%

RevvityRVTY

$12.41B+9.2%

Agilent TechnologiesA

$32.65B+7.0%

Fulgent Genetics, Inc.FLGT

$496.57M-4.8%

FAQ

What is Cytek Biosciences, Inc.'s market capitalization?

Cytek Biosciences, Inc. (CTKB) reported market capitalization of $572.1M in Q2 2026.

How has Cytek Biosciences, Inc.'s market capitalization changed year-over-year?

Cytek Biosciences, Inc.'s market capitalization increased by 39.8% year-over-year, from $409.11M to $572.1M.

What is the long-term trend for Cytek Biosciences, Inc.'s market capitalization?

Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s market capitalization has grown at a -26.3% compound annual growth rate (CAGR), from $2.19B to $645.72M.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.